ArticleFrontiers in pharmacology2024

Risk of immune system and skin and subcutaneous tissue related adverse events associated with oxaliplatin combined with immune checkpoint inhibitors: a pharmacovigilance study.

Chunhong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.